ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE PATIENTS.

Gaia Pellegatta  1     Sara Lo Pumo  1     Giorgia Bodini  1     Isabella Baldissarro  2     Edoardo G. Giannini     Vincenzo Savarino     Edoardo Vincenzo Savarino    
1 University of Genoa,Division of Gastroenterology, Department of Internal Medicine,Genova,Italy
2 University of Genoa,Division of Gastroenterology,

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing